United States Government Publishing Office
publisher
pbl
distributor
dst
United States
National Archives and Records Administration
Office of the Federal Register
author
aut
Government Organization
text
government publication
eng
FR
Regulatory Information
2020_register
executive
2020-02-20
article
Compounding Animal Drugs From Bulk Drug Substances; Draft Guidance for Industry; Availability; Reopening of Comment Period
Notices
D09002ee1c111b241
D09002ee1c111b40b
United States
Department of Health and Human Services
originator
org
United States Government Agency or Subagency
United States
Food and Drug Administration
originator
org
United States Government Agency or Subagency
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability that published in the Federal Register on November 20, 2019. In that notice, FDA requested comments on the draft guidance for industry (GFI) #256 entitled ``Compounding Animal Drugs from Bulk Drug Substances.'' FDA is reopening the comment period to update comments and to receive any new information.
85 FR 9783
https://www.govinfo.gov/app/details/FR-2020-02-20/2020-03312
2020-03312
fr20fe20-67
4164-01-P
Docket No. FDA-2018-D-4533
https://www.govinfo.gov/app/details/FR-2020-02-20/2020-03312
https://www.govinfo.gov/content/pkg/FR-2020-02-20/html/2020-03312.htm
https://www.govinfo.gov/content/pkg/FR-2020-02-20/pdf/2020-03312.pdf
2 p.
9783
9784
85 FR 9783
Compounding Animal Drugs From Bulk Drug Substances; Draft Guidance for Industry; Availability; Reopening of Comment Period; Federal Register Vol. 85, Issue
NOTICE
2020-03312
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
2020-06-07
Docket No. FDA-2018-D-4533
4164-01-P
2020-03312
Notice of availability; reopening of comment period.
The Food and Drug Administration (FDA or the Agency) is reopening the comment period for the notice of availability that published in the Federal Register on November 20, 2019. In that notice, FDA requested comments on the draft guidance for industry (GFI) #256 entitled ``Compounding Animal Drugs from Bulk Drug Substances.'' FDA is reopening the comment period to update comments and to receive any new information.
FDA is reopening the comment period on the document published November 20, 2019 (84 FR 64085). Submit either electronic or written comments on the draft guidance by June 17, 2020, to ensure that the Agency considers your comments on this draft guidance before it begins work on the final version of the guidance.
Eric Nelson, Division of Compliance (HFV-230), Center for Veterinary Medicine, Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-402-7001, cvmcompliance@fda.hhs.gov.
Guidance:
Compounding Animal Drugs From Bulk Drug Substances,
cvmcompliance@fda.hhs.gov
https://www.govinfo.gov/content/pkg/FR-2015-09-18/pdf/2015-23389.pdf
https://www.regulations.gov
Federal Register
Vol. 85, no. 34
Office of the Federal Register, National Archives and Records Administration
2020-02-20
continuing
daily
deposited
born digital
380 p.
Table of Contents:
AE 2.7:
GS 4.107:
AE 2.106:
KF70.A2
https://www.govinfo.gov/app/details/FR-2020-02-20
P0b002ee1a5da9ac4
0097-6326
0042-1219
0364-1406
769-004-00000-9
000582072
f:fr20fe20
https://www.govinfo.gov/app/details/FR-2020-02-20
https://www.govinfo.gov/content/pkg/FR-2020-02-20/pdf/FR-2020-02-20.pdf
https://www.govinfo.gov/content/pkg/FR-2020-02-20/xml/FR-2020-02-20.xml
fdlp
9661
10032
DGPO
2020-02-20
2023-09-28
FR-2020-02-20
machine generated
eng
FR
FR-2020-02-20
85
34